How we think about early-stage healthcare and AI.
Our investment thesis, our diligence methodology, and our perspective on where the sector is heading. Published openly because credibility is earned in public.
Four conditions we look for.
- I
Specialized knowledge creates durable advantage
The best opportunities sit in domains where even understanding the problem requires specialized expertise. Diagnostics, clinical workflows, regulated AI, and therapeutics all qualify. These are the deals where deep sector knowledge creates durable advantage.
- II
Founder capability matches the problem complexity
Domain complexity punishes founders who do not know the space cold. We weight founder fit to the specific problem more heavily than founder credentials in general.
- III
Exit paths are mapped before entry
Healthcare and life sciences have well-defined acquirer landscapes. We map realistic acquirers and follow-on investors before we commit capital, not after.
- IV
Unit economics survive regulation
Regulatory reality in this sector breaks business models that look elegant on a slide. We pressure-test economics against realistic reimbursement, approval timelines, and compliance cost before investing.
The Signal Report.
Every deal we bring to our Investors includes a Signal Report written by a domain expert in the relevant sector. This is not a deal memo. It is a specialized review of the thesis, the science, the clinical model, or the technical claim.
Signal Reports answer the questions an Investor cannot answer for themselves, with the rigor of someone who has lived in the space for years.
"The questions an Investor cannot answer for themselves, answered with the rigor of someone who has lived in the space for years."
What a Signal Report contains
- 01Technical or clinical validation of the core thesis
- 02Competitive positioning against the realistic comparable set
- 03Regulatory and approval risk assessment
- 04Market timing analysis
- 05Expert recommendation with explicit confidence level
Where the thesis applies.
- 01
Diagnostic technology and clinical operations
Platforms and tools that improve diagnosis accuracy, speed, and accessibility.
- 02
Specialty pharmaceutical assets
Post-development assets with validated clinical data and clear commercial pathways.
- 03
Applied AI in regulated environments
AI applications where validation matters and output quality is measurable.
- 04
Longevity and healthspan
Therapeutics, diagnostics, and platforms extending healthy human lifespan.
- 05
Data security
Platforms and technologies protecting health data, clinical systems, and digital infrastructure across the healthcare and life sciences ecosystem.